Tab Application Banner
  • Users Online: 1891
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
TOPICAL REVIEW
Year : 2021  |  Volume : 16  |  Issue : 3  |  Page : 304-310

Anxiety and depression in childhood rheumatologic conditions: A topical review


1 Department of Family Medicine, College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA
2 Department of Pediatrics, Division of Pediatric Rheumatology, Duke University Medical Center, Durham, NC, USA
3 Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada
4 Department of Pediatrics, Division of Pediatric Rheumatology, Duke University Medical Center, Durham, NC; Departments of Pediatrics and Medical Social Sciences, Northwestern University Feinberg School of Medicine; Division of Pediatric Rheumatology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA

Correspondence Address:
Dr. Natoshia R Cunningham
Department of Family Medicine, College of Human Medicine, Michigan State University, 15 Michigan Street NE, Grand Rapids, Michigan 49503
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/injr.injr_127_20

Rights and Permissions

This topical review summarizes recent literature on mental health symptoms experienced by children diagnosed with rheumatologic conditions including childhood-onset systemic lupus erythematosus (cSLE), juvenile idiopathic arthritis (JIA), and juvenile dermatomyositis (JDM). Studies, while limited, generally indicate that anxiety and depressive symptoms may be more common among children diagnosed with rheumatologic conditions than non-chronically ill children. Although the rates of clinically significant symptoms are not consistently reported across studies, overall anxiety and depressive symptom rates in cSLE vary between 34%–37% and 6.7%–59%, respectively. A recent systematic review of JIA suggests between 7% and 64% of participants experienced elevated anxiety, and between 7% and 36% of participants reported clinically significant depressive symptoms. Approximately 40% of youth with JDM may experience general psychological distress, but more research is needed. In the available literature, there is mixed support for higher rates of anxiety in JIA as compared to cSLE, and higher rates of depressive symptoms in cSLE as compared to JIA, whereas mental health functioning in JDM is less well understood. Mental health functioning in youth with rheumatologic conditions may be related to increased disease-related impairment. Using consistent mental health screening measures with clinically validated cutoffs would enhance insight into the frequency and impact of anxiety and depressive symptoms experienced. Knowledge would also be enhanced by conducting studies with ethnically representative samples to identify potential disparities in care. An improved understanding of mental health functioning in pediatric patients presenting for rheumatologic care may inform the development and testing of tailored and effective treatments.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1863    
    Printed40    
    Emailed0    
    PDF Downloaded50    
    Comments [Add]    

Recommend this journal